Trending intel short linkNo signup · Email subscription
31.4k following · Innovative Drug / Approval / China

Changes in the NDA approval efficiency of domestically developed innovative drugs

Observe the approval cycle from application acceptance to approval of domestic first-in-class drugs such as KX-826, and compare the impact of the priority review channel on the launch speed of innovative drugs.

31.4k following89.9k views
By clicking “Confirm”, you acknowledge that you have read and agree to
/ /
Unlimited Free Public IntelligenceOnly key changes trigger emailsUnsubscribe anytime
Monitor official signalsTrack announcements, filings, company statements, prices, and investor updates.
AI summaryFilter repeated noise and provide concise conclusions with source confidence.
Notify only when usefulNo daily spam. You only get emailed when meaningful progress appears.